NCT04951193

Brief Summary

The purpose of this study is to evaluate a mobile application (app) called "Goal2QuitVaping" to help adolescents quit vaping nicotine. Goal2QuitVaping was developed by our research team to assist with quitting vaping. Participants will be randomly assigned to either download the mobile app, "Goal2QuitVaping", or not. If provided with Goal2QuitVaping, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 4 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

June 25, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2023

Completed
12 months until next milestone

Results Posted

Study results publicly available

June 7, 2024

Completed
Last Updated

August 21, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

June 25, 2021

Results QC Date

April 4, 2024

Last Update Submit

July 30, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Mean Score of Depressive Symptoms

    Patients will self report depressive symptoms weekly for 4 weeks via the Beck Depression Inventory-II. The range of scores possible are 0 - 63, where lower scores are indicative of lower symptoms of depression. This outcome will measure change from baseline at week 4.

    Up to 4 weeks

  • Average Vapes Per Day at Week 4

    Assessed using the Timeline Followback during each weekly assessment. Average vapes per day at week 4.

    Week 4

  • E-cigarette Dependence

    Assessed at baseline via the 10-item Penn State Electronic Cigarette Dependence Index (ECDI). Change from baseline at week 4. The scores range from 0-20 with 0-3= not dependent, 4-8 low dependence, 9-12 medium dependence, 13+ = high dependence.

    Up to 4 weeks

  • Number/Duration of Quit Attempts

    Assessed during the Timeline Followback. Total number of quit attempts across all 4 weeks

    Across all 4 weeks

  • 7-day Point Prevalence Abstinence

    Assessed during the Timeline Followback. At any point during the study across all 4 weeks.

    At any point during the study

Study Arms (2)

Goal2QuitVaping

EXPERIMENTAL

Participants in the Goal2QuitVaping group will be asked to download the Goal2QuitVaping app to their smartphone. Goal2QuitVaping focuses on mood management as well as on quitting vaping nicotine. Participants will be asked to use Goal2QuitVaping regularly, at least once per day, for the study duration. Participants will also be asked to complete questionnaires weekly for 4 weeks.

Behavioral: Behavioral Activation Therapy app

Treatment as Usual

OTHER

Participants in the treatment as usual group will be provided with educational material about quitting vaping nicotine and it will be suggested that they discuss any questions about mood management and about quitting vaping with their primary care provider. The educational material is from the National Cancer Institute's SmokeFree Teen website and includes information on recognizing reasons for quitting vaping, avoiding dual use of e-cigarettes and other tobacco products, setting a quit date, understanding triggers, and accessing social support.

Behavioral: Treatment as Usual

Interventions

Goal2QuitVaping focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.

Goal2QuitVaping

Participants will be provided educational material about quitting vaping nicotine with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.

Treatment as Usual

Eligibility Criteria

Age16 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age 16-20
  • vaped nicotine on ≥20 days out of the last 30
  • elevated depressive symptoms, defined as a score of ≥10 on Patient Health Questionnaire-8 (PHQ-8) during preliminary screening and the Adolescent Patient Health Questionnaire-9 (PHQ-9A) at final eligibility
  • currently own an iOS or Android smartphone
  • report willingness to utilize an app for quitting vaping nicotine (response of "yes" on yes/no item)
  • have a valid e-mail address that is checked regularly or regular access to text messages (for follow-up assessments)
  • ability to read the consent form
  • has been seen (in person or remotely) by a primary care physician within the last year

You may not qualify if:

  • smoked cigarettes or used other tobacco products on ≥9 days out of the last 30
  • severe visual impairment
  • currently receiving treatment for vaping or tobacco use
  • current suicidal ideation, defined as a response ≥1 on item nine of the PHQ-9A or ≥2 on item 9 of the BDI-II
  • household member currently enrolled in the study
  • inability to read the consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

DepressionAdolescent Behavior

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Dr. Jennifer Dahne
Organization
MUSC

Study Officials

  • Jennifer Dahne, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 25, 2021

First Posted

July 6, 2021

Study Start

June 1, 2021

Primary Completion

May 24, 2023

Study Completion

June 21, 2023

Last Updated

August 21, 2024

Results First Posted

June 7, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations